From June 5438 to February 2000, the company established the first new drug research and development laboratory. In the same month, the first new liposome drug for treating deep fungal infection in China was introduced from the United States, and the drug import license was issued by the State Food and Drug Administration of the United States.
In September, 20001year, the company moved into Guangzhou Mayor Building.
In May 2002, the company set up the second new drug research and development laboratory.
In March 2003, the company formally decided to establish Guangzhou Langsheng Pharmaceutical Co., Ltd., located in Guangzhou Science City.
In May, 2003, Langsheng Pharmaceutical was formally registered and established, and the contraceptive pill was established as the first professional development direction of the enterprise. In August of the same year, it obtained the project license of pharmaceutical enterprises issued by the US Food and Drug Administration of Guangdong Province.
In February, 2004, the clinical approval of levonorgestrel enteric-coated tablets was obtained from the US Food and Drug Administration, and the clinical research was allowed. The company became the first pharmaceutical company in the world to study levonorgestrel enteric-coated tablets as an emergency contraceptive.
In April 2004, an enterprise project covering an area of 20,000 square meters in Guangzhou Science City broke ground.
From June 5, 2004 to 10, we obtained the second clinical approval for contraceptives issued by the US Food and Drug Administration.
From June 5, 2004 to 2004 10, the company built the first modern steroid technology production line according to the GMP standards of WHO and US Food and Drug Administration.
On February 28th, 2005, the new factory building and office laboratory building were completed, and the company officially moved out of Guangzhou Mayor Building.
In April 2005, we signed a cooperation agreement with the Chinese University of Hong Kong on the first-class anti-tumor drugs.
In June 2005, the first pilot workshop of freeze-dried injection was built and put into use.
From June to 10, 2007, we reached an international strategic cooperation agreement with American HM company.
In June, 2008, 5438+ 10 was awarded the national new drug certificate and production approval of levonorgestrel enteric-coated tablets by the US Food and Drug Administration.
In June 2008, it officially passed the GMP inspection and certification of Food and Drug Administration, and obtained the GMP certificate of steroid hormone solid and oral preparation workshop in July of the same year.
In August 2008, the company applied to the US Food and Drug Administration for more than ten new birth control drugs. So far, the company has obtained the clinical approval of four new contraceptives, one of which is levonorgestrel enteric-coated tablets.
In September 2008, the company launched the first issue of Mei Dan advertising ideas and pictures.
In June, 2008, 5438+ 10, Langsheng Pharmaceutical opened in official website.
In 2009, 1.400 customer service telephone was opened.
In April 2009, the company participated in the 6 1 National Drug Fair held in Zhengzhou, Henan.
In July 2009, the brand image of Mei Dan was upgraded in an all-round way, and the cartoon image of Mei Dan was grandly launched.
In July 2009, the company's product website-Murray. Com has been completed and successfully opened.
In July 2009, Mei Dan founded Charm magazine.
In August 2009, the company participated in the 5th Reproductive Health Expo.
In September, 2009, the first commercial film of Maidan was completed, and the film advertisement was shot and produced.
On September 6th, 2009, the invention patent of 16: "Formulation for delaying the dissolution of solid oral contraceptives or drugs for terminating pregnancy and its application" was authorized by China National Intellectual Property Administration with the patent number of ZL02 148956.4.
In June 2009, the company participated in the 62nd National Drug Fair held in Chengdu, Sichuan.
In June, 2009, 165438+ 10, the mobile media advertisement was officially launched.
0.75 mg of Medan was listed in June 5438+February, 2009.
From June 5438 to February 2009, the company was awarded the title of "Key Overseas Chinese Entrepreneurship Team of the State Council Overseas Chinese Affairs Office" by the State Council Overseas Chinese Affairs Office.
From June 2008 to February 2009, Lu Zhijun, the general manager, was awarded the "Second Outstanding Entrepreneurship Award of 100 Overseas Chinese" by the Overseas Chinese Affairs Office of the State Council.
2010 65438+10-March, the company's TV advertisements were broadcast in prime time on Jiangsu Satellite TV and Hunan Satellite TV.